RxDoctor Payments Data

Lauren Davidson

Family · State College, PANPI 1255975892

Payments from drug & device makers

$3,347in general payments, 2019–2025

Across 179 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$826
  • AbbVie$657
  • Sumitomo Pharma America, Inc.$650
  • Urogen Pharma, Inc.$210
  • Johnson & Johnson$178
  • AstraZeneca$175
  • plus $652 from 13 others

What the payments were for

  • Food & beverage$3,09392%
  • Education$2548%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,347 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$35,294
Medicare patients
232
Services billed
1,274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron64$48,484
MyrbetriqMirabegron22$14,823
ElmironPentosan Polysulfate Sodium12$9,721
Silodosin11$2,254
Tamsulosin Hcl189$2,251
Finasteride156$1,939
Methenamine Hippurate27$1,657
Solifenacin Succinate21$1,018
Oxybutynin Chloride ErOxybutynin Chloride37$795
Dutasteride27$764
Alfuzosin Hcl ErAlfuzosin Hcl49$699
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst28$322
Ampicillin Trihydrate16$151
Cephalexin23$147
Oxybutynin Chloride15$142

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$650$48,48464 claims
Astellas Pharma US IncMyrbetriq$826$14,82322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,717 family providers in Pennsylvania.

Other family in State College

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →